[1]
|
miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers
Pathology - Research and Practice,
2022
DOI:10.1016/j.prp.2022.153886
|
|
|
[2]
|
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3
2022
DOI:10.1016/B978-0-323-99283-1.00008-2
|
|
|
[3]
|
Potential Therapeutic Strategies to Combat HCC
Current Molecular Pharmacology,
2022
DOI:10.2174/1874467215666220103111009
|
|
|
[4]
|
Effect of Quercetin and Fingolimod, Alone or in Combination, on the Sphingolipid Metabolism in HepG2 Cells
International Journal of Molecular Sciences,
2022
DOI:10.3390/ijms232213916
|
|
|
[5]
|
miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers
Pathology - Research and Practice,
2022
DOI:10.1016/j.prp.2022.153886
|
|
|
[6]
|
Antihepatoma activity of multifunctional polymeric nanoparticles via inhibition of microtubules and tyrosine kinases
Nanomedicine,
2020
DOI:10.2217/nnm-2019-0349
|
|
|
[7]
|
Regulation of the Intracellular ROS Level Is Critical for the Antiproliferative Effect of Quercetin in the Hepatocellular Carcinoma Cell Line HepG2
Nutrition and Cancer,
2019
DOI:10.1080/01635581.2018.1559929
|
|
|
[8]
|
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma
Artificial Cells, Nanomedicine, and Biotechnology,
2017
DOI:10.1080/21691401.2017.1388250
|
|
|
[9]
|
Role of Transcription Factors in Gastrointestinal Malignancies
2017
DOI:10.1007/978-981-10-6728-0_36
|
|
|
[10]
|
Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression
Biochemical and Biophysical Research Communications,
2016
DOI:10.1016/j.bbrc.2016.09.035
|
|
|